Jonathan Coles
Has grant
Professor and Honorary Consultant
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Professor Jonathan Coles is a faculty member at the University of Cambridge, United Kingdom. As an Honorary Consultant, he specializes in neurotrauma and traumatic brain injury, focusing on cerebral metabolic derangements and connectivity issues in affected patients. His recent research includes studies on glucose metabolism following brain injuries, the impact of amyloid-β and tau deposition on cognitive decline, and guidelines for temperature management in stroke patients.
Recent Grants
Grant: Close
International Collaboration On Neuroinflammation in Traumatic Brain Injury (ICON-TBI)
Open Date: 2017-03-31
Close Date: 2022-10-31
Grant: Close
MICA: Detecting ictogenicity and epileptogenesis
Open Date: 2015-03-01
Close Date: 2020-02-29
Grant: Close
MICA: Training and Novel Probes Programme in PET Neurochemistry - PET Call
Open Date: 2013-12-01
Close Date: 2018-11-30
Grant: Close
Collaborative European NeuroTrauma Effectiveness Research in TBI
Open Date: 2013-10-01
Close Date: 2020-03-31
Grant: Close
Imaging mechanisms of energy failure following head injury.
Open Date: 2011-03-01
Close Date: 2013-02-28
Articles (17)
Traumatic brain injury (TBI) is a major public health concern with significant consequences across various domains. Following the primary event, secondary injuries compound the outcome after TBI, with disrupted glucose metabolism emerging as a relevant factor. This narrative review summarises the existing literature on post-TBI alterations in glucose metabolism. After TBI, the brain undergoes dynamic changes in brain glucose transport, including alterations in glucose transporters and kinetics, and disruptions in the blood–brain barrier (BBB). In addition, cerebral glucose metabolism transitions from a phase of hyperglycolysis to hypometabolism, with upregulation of alternative pathways of glycolysis. Future research should further explore optimal, and possibly personalised, glycaemic control targets in TBI patients, with GLP-1 analogues as promising therapeutic candidates. Furthermore, a more fundamental understanding of alterations in the activation of various pathways, such as the polyol and lactate pathway, could hold the key to improving outcomes following TBI.
Year:
2024
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Year:
2022
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Collaborators (17)
Martin Nørgaard
Københavns Universitet
William Stewart
Adjunct Professor
University of Pennsylvania
Tilak Das
Cambridge University Hospitals
Colm McGinnity
King’s College London
Henning Hermanns
Amsterdam UMC Locatie VUmc
Taylor W. Schmitz
-
Naomi Thomas
-
Peter Bragge
MONASH UNIVERSITY
Jeroen Hermanides
-
David Nelson
Karolinska Institutet
Veronique De Keyser
Antwerp University Hospital
Alexander Hammers
King’s College London
Carmen Lopez Soto
King's College Hospital NHS Foundation Trust
Joukje van der Naalt
neurologist, MD PhD Professor in Neurotraumatology
University Medical Center Groningen
Jussi P. Posti
-
Peter Nestor
Professor of Cogntive Neurology
-
Randeep Mullhi
University Hospitals Birmingham NHS Foundation Trust
Make your next move.
Prepare your application
Review drafts before you send them.